Red Mountain Compounding Recalls S-Glycerin Injection Due to Sterility Concerns
Red Mountain Compounding Pharmacy is recalling S-Glycerin 72% Injection Solution because the product lacks assurance of sterility.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a Severe rating under the rubric for significant injury or property damage risks, such as sterility failures in injectable drugs.
Plain-English summary
First Royal Care Co. LLC, doing business as Red Mountain Compounding Pharmacy, is recalling S-Glycerin 72% Injection Solution, 30ML glass vials. The recall was initiated due to a lack of assurance of sterility in the product.
The affected product consists of 5x30 ML vials distributed nationwide in the USA. Specific lots involved in the recall include S05142019DT@09 (Exp 8/14/19), S07162019DT@14 (Exp 10/16/19), and S07232019DH@06 (Exp 10/23/19).
Consumers and healthcare providers should stop using the affected product and contact the recalling firm for further instructions.
The recalled product
- Product
- S-GLYCERIN 72% INJECTION SOLN, 30ML glass vial, Red Mountain Compounding RX
- Category
- Drug — Injectable
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Lot #: S05142019DT@09
- Exp 8/14/19
- S07162019DT@14
- Exp 10/16/19
- S07232019DH@06
- Exp 10/23/19
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 100 recalled by First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 100 products in this recall →Related recalls
Same manufacturer · First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy
See all →- SevereMIT/B12 Compounded Injection Recalled for Sterility Assurance Concerns
FDA (Drugs) · 2021-11-03
- HighTestosterone Ultra 250MG/ML Recalled for Sterility Assurance Concerns
FDA (Drugs) · 2021-11-03
- SevereRed Mountain Compounding Test Cypionate Sterility Assurance Recall
FDA (Drugs) · 2021-11-03
- SevereTEST CYP/PROP Compounded Injection Recalled for Sterility Assurance Concerns
FDA (Drugs) · 2021-11-03
- HighTEST CYP 25MG/ML Injectable Lacks Assurance of Sterility
FDA (Drugs) · 2021-11-03
Same hazard · sterility failure
See all →- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22
Similar recalls
- SevereAscorbic/Glutathione Eye Solution Recalled for Sterility Concerns
FDA (Drugs) · 2021-11-03
- HighPyridoxine HCL Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2021-11-03
- SevereAdvanced Compounding Pharmacy Recalls Glycerin Injectable Due to Sterility Concerns
FDA (Drugs) · 2015-06-03
- ModerateMethylcobalamin injection recalled due to sterility assurance concerns
FDA (Drugs) · 2021-11-03
- Severe
- HighCalcium Gluconate 10% Injectable Recalled for Sterility Assurance
FDA (Drugs) · 2021-11-03